Search Results

There are 5612 results for: content related to: Dose-ranging study of mesalamine (PENTASA) enemas in the treatment of acute ulcerative proctosigmoiditis: Results of a multicentered placebo-controlled trial

  1. Therapeutic Approaches to the Treatment of Ulcerative Colitis

    Inflammatory Bowel Disease: Translating basic science into clinical practice

    Stephan R. Targan, Fergus Shanahan, Loren C. Karp, Pages: 415–443, 2010

    Published Online : 18 MAY 2010, DOI: 10.1002/9781444318418.ch28

  2. Inflammatory Bowel Disease

    Textbook of Gastroenterology

    William F. Stenson, Stephen B. Hanauer, Russell D. Cohen, Pages: 1386–1472, 2009

    Published Online : 17 FEB 2009, DOI: 10.1002/9781444303254.ch57

  3. You have free access to this content
    Medical therapy of ulcerative proctitis and proctosigmoiditis, including refractory disease

    Inflammatory Bowel Diseases

    Volume 1, Issue 3, Autumn (Fall) 1995, Pages: 207–219, Dr. Alain Bitton and Mark A. Peppercorn

    Article first published online : 14 DEC 2006, DOI: 10.1002/ibd.3780010308

  4. Chemistry, Pharmacology, Pharmacokinetics, and Clinical Applications of Mesalamine for the Treatment of Inflammatory Bowel Disease

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 14, Issue 4, July-August 1994, Pages: 385–398, Ralph E. Small and Charles C. Schraa

    Article first published online : 18 JAN 2012, DOI: 10.1002/j.1875-9114.1994.tb02829.x

  5. You have free access to this content
    Oral mesalamine and clinical remission are associated with a decrease in the extent of long-standing ulcerative colitis

    Inflammatory Bowel Diseases

    Volume 12, Issue 7, July 2006, Pages: 537–542, Michael F. Picco, Murli Krishna, John R. Cangemi and Donna Shelton

    Article first published online : 14 DEC 2006, DOI: 10.1097/01.ibd.0000225345.29603.7d

  6. You have free access to this content
    Once daily oral mesalamine compared to conventional dosing for induction and maintenance of remission in ulcerative colitis: A systematic review and meta-analysis

    Inflammatory Bowel Diseases

    Volume 18, Issue 9, September 2012, Pages: 1785–1794, Brian G. Feagan and John K. MacDonald

    Article first published online : 29 MAY 2012, DOI: 10.1002/ibd.23024

  7. Impact of MMX® mesalamine on improvement and maintenance of health-related quality of life in patients with ulcerative colitis

    Inflammatory Bowel Diseases

    Paul Hodgkins, Linnette Yen, Aaron Yarlas, Robyn Karlstadt, Dory Solomon and Sunanda Kane

    Article first published online : 30 MAY 2012, DOI: 10.1002/ibd.23022

  8. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis

    Intervention Review

    The Cochrane Library

    Brian G Feagan and John K MacDonald

    Published Online : 17 OCT 2012, DOI: 10.1002/14651858.CD000543.pub3

  9. You have free access to this content
    Clinical trial: A novel high-dose 1 g mesalamine suppository (salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis

    Inflammatory Bowel Diseases

    Volume 16, Issue 11, November 2010, Pages: 1947–1956, Tilo Andus, Andreas Kocjan, Moritz Müser, Andrey Baranovsky, Tatyana L. Mikhailova, Tatyana D. Zvyagintseva, Andrey E. Dorofeyev, Yurii S. Lozynskyy, Ingolf Cascorbi, Manfred Stolte, Michael Vieth, Karin Dilger, Ralf Mohrbacher and Roland Greinwald

    Article first published online : 22 MAR 2010, DOI: 10.1002/ibd.21258

  10. You have free access to this content
    Optimizing therapy in patients with pancolitis

    Inflammatory Bowel Diseases

    Volume 11, Issue 10, October 2005, Pages: 937–946, Carmen Cuffari, Daniel H Present, Theodore M Bayless and Gary R Lichtenstein

    Article first published online : 14 DEC 2006, DOI: 10.1097/01.mib.0000179469.86500.ac

  11. You have free access to this content
    Mesalazine granules are superior to Eudragit-L-coated mesalazine tablets for induction of remission in distal ulcerative colitis – a pooled analysis

    Alimentary Pharmacology & Therapeutics

    Volume 34, Issue 9, November 2011, Pages: 1115–1122, L. Leifeld, R. Pfützer, J. Morgenstern, P. R. Gibson, Y. Marakhouski, R. Greinwald, R. Mueller and W. Kruis

    Article first published online : 19 SEP 2011, DOI: 10.1111/j.1365-2036.2011.04840.x

  12. You have free access to this content
    Comparative cost-effectiveness of strategies to prevent postoperative clinical recurrence of Crohn's disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 9, September 2012, Pages: 1608–1616, Glen A. Doherty, Rebecca A. Miksad, Adam S. Cheifetz and Alan C. Moss

    Article first published online : 8 SEP 2011, DOI: 10.1002/ibd.21904

  13. You have free access to this content
    Strategies in maintenance for patients receiving long-term therapy (SIMPLE): A study of MMX mesalamine for the long-term maintenance of quiescent ulcerative colitis

    Inflammatory Bowel Diseases

    Volume 18, Issue 6, June 2012, Pages: 1026–1033, Sunanda Kane, Seymour Katz, M. Mazen Jamal, Michael Safdi, Ben Dolin, Dory Solomon, Mary Palmen and Karen Barrett

    Article first published online : 11 AUG 2011, DOI: 10.1002/ibd.21841

  14. You have free access to this content
    Maintaining remissions across the lifespan. A roundtable discussion with Crohn's disease experts

    Inflammatory Bowel Diseases

    Volume 10, Issue 8, July 2004, Pages: S11–S21, Gary R. Lichtenstein, Carmen Cuffari, Sunanda V. Kane, Stephen Hanauer and Daniel H. Present

    Article first published online : 14 DEC 2006, DOI: 10.1097/00054725-200407002-00003

  15. 5-aminosalicylates

    Pocket Guide to Gastrointestinal Drugs

    Hannah L. Miller, Francis A. Farraye, Pages: 82–99, 2014

    Published Online : 10 JAN 2014, DOI: 10.1002/9781118481530.ch6

  16. Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis

    Intervention Review

    The Cochrane Library

    John K Marshall, Marroon Thabane, A Hillary Steinhart, Jamie R Newman, Anju Anand and E Jan Irvine

    Published Online : 20 JAN 2010, DOI: 10.1002/14651858.CD004115.pub2

  17. You have free access to this content
    Crohn's is not a 6-week disease. Lifelong management of mild to moderate Crohn's disease

    Inflammatory Bowel Diseases

    Volume 10, Issue 8, July 2004, Pages: S2–S10, Gary R. Lichtenstein, Stephen B. Hanauer, Sunanda V. Kane and Daniel H. Present

    Article first published online : 14 DEC 2006, DOI: 10.1097/00054725-200407002-00002

  18. You have free access to this content
    Once-daily versus multiple-daily mesalamine for patients with ulcerative colitis: A meta-analysis

    Journal of Digestive Diseases

    Volume 13, Issue 4, April 2012, Pages: 200–207, Jin Lu TONG, Mei Lan HUANG, Xi Tao XU, Yu Qi QIAO and Zhi Hua RAN

    Article first published online : 21 MAR 2012, DOI: 10.1111/j.1751-2980.2012.00576.x

  19. You have free access to this content
    Efficacy and safety of mesalamine 1 g HS versus 500 mg BID suppositories in mild to moderate ulcerative proctitis: A multicenter randomized study

    Inflammatory Bowel Diseases

    Volume 11, Issue 7, July 2005, Pages: 625–630, Mark Lamet, Theodore Ptak, Chrystian Dallaire, Umed Shah, Michael Grace, Jean Spenard and Danielle de Montigny

    Article first published online : 14 DEC 2006, DOI: 10.1097/01.MIB.0000171277.70404.40

  20. You have free access to this content
    Mesalamine in pediatric inflammatory bowel disease: A 10-year experience

    Inflammatory Bowel Diseases

    Volume 2, Issue 4, Winter 1996, Pages: 229–235, Ian D. D'Agata, Tsafrir Vanounou and Dr. Ernest Seidman

    Article first published online : 14 DEC 2006, DOI: 10.1002/ibd.3780020402